Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies. Our dedicated team, state-of-the-art facilities, and unparalleled expertise are crucial for advancing products from development to commercial launch. Arranta Bio continues to expand capacity and development and manufacturing services across two sites with three distinct technology platforms designed to meet the evolving demands of our clients and partners.

Team Members

Traci Kyes

Traci Kyes

VP of Commercial Operations

Jeff Heiser

Jeff Heiser

Senior Director, Head of Process Development and Analytical Development


Aaron Cowley

Chief Scientific Officer

Nick Mazzucca

Nicholas Mazzucca

Head of Proposals